Opal Therapeutics Inc: Ledger

Stories naming Opal Therapeutics Inc. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Investor	Rounds	Invested
No investors recorded yet. Know one?

Company	Kind	Announced	Price	Sources
Opal Therapeutics Inc is not recorded as having acquired anything.

Series A US$6m

OPAL Therapeutics Inc, Immunotherapy Start Up, Raises $US6m Series A to target HIV and Hepatitis C.

OPAL Therapeutics raised a US$6 million Series A, with GBS Venture Partners leading a syndicate including Alloy Ventures, Alta Partners and Uniseed, to develop HIV and hepatitis C immunotherapies from University of Melbourne technology.

GBS Ventures 19 Dec 2005 Opal Therapeutics Inc University of Melbourne Alloy Ventures Alta Partners GBS Venture Partners Ltd.Uniseed

Opal Therapeutics Inc

Funding history

Investors

What Opal Therapeutics Inc bought

People

Coverage

Opal Therapeutics Inc and Massachusetts General Hospital enter Joint Development Collaboration and Initiate HIV Immunotherapy Clinical Studies - Therapeutic Vaccine Trials to Start in London, UK

OPAL Therapeutics Inc, Immunotherapy Start Up, Raises $US6m Series A to target HIV and Hepatitis C.